Howard Rosen's most recent trade in Kala Pharmaceuticals Inc was a trade of 5,450 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kala Pharma Inc | Howard Rosen | Director | 15 Jun 2025 | 5,450 | 5,450 | - | - | Stock Option (right to buy) | ||
| Kala Pharma Inc | Howard Rosen | Director | 15 Jun 2025 | 2,450 | 16,240 (0%) | 0% | 0 | Common Stock | ||
| Kala Pharma Inc | Howard Rosen | Director | 11 Jun 2024 | 3,150 | 3,150 | - | - | Stock Option (right to buy) | ||
| Kala Pharma Inc | Howard Rosen | Director | 11 Jun 2024 | 1,400 | 13,887 (0%) | 0% | 0 | Common Stock | ||
| Acelrx Pharma Inc | Howard Rosen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 3,487 | 3,487 | - | - | Stock Option (Right to Buy) | |
| Acelrx Pharma Inc | Howard Rosen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 581 | 5,293 (0%) | 0% | 0 | Common Stock | |
| Kala Pharma Inc | Howard Rosen | Director | 16 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) |